Implication of non-coding PAX6 mutations in aniridia
There is an increasing implication of non-coding regions in pathological processes of genetic origin. This is partly due to the emergence of sophisticated techniques that have transformed research into gene expression by allowing a more global understanding of the genome, both at the genomic, epigenomic and chromatin levels. Here, we implemented the analysis of PAX6, whose coding loss-of-function variants are mainly implied in aniridia, by studying its non-coding regions (untranslated regions, introns and cis-regulatory sequences). In particular, we have taken advantage of the development of high-throughput approaches to screen the upstream and downstream regulatory regions of PAX6 in 47 aniridia patients without identified mutation in the coding sequence. This was made possible through the use of custom targeted resequencing and/or CGH array to analyze the entire PAX6 locus on 11p13. We found candidate variants in 30 of the 47 patients. 9/30 correspond to the well-known described 3′ deletions encompassing SIMO and other enhancer elements. In addition, we identified numerous different variants in various non-coding regions, in particular untranslated regions. Among these latter, most of them demonstrated an in vitro functional effect using a minigene strategy, and 12/21 are thus considered as causative mutations or very likely to explain the phenotypes. This new analysis strategy brings molecular diagnosis to more than 90% of our aniridia patients. This study revealed an outstanding mutation pattern in non-coding PAX6 regions confirming that PAX6 remains the major gene for aniridia.
KeywordsAniridia Eye development PAX6 Non-coding mutation Cis-regulatory region 5′UTR Minigene assay
We acknowledge generous support from the families published in this article. We thank Salvador Marti and Virginia Corrochano from CIBERER Biobank (Valencia, Spain) for their help in the generation of LCLs. This work was supported by Gêniris funding awarded to Dr Julie Plaisancié, Retina France funding awarded to Jean-Michel Rozet and Patrick Calvas, Spanish Institute of Health Carlos III (ISCIII)/European Regional Development Fund (ERDF) (PI17_01164 and CP12/03256), Spanish Ministry of Economy and Competitiveness/ERDF (MINECO, SAF2013-46943-R), Spanish Federation of Rare Diseases (FEDER) and Mutua Madrileña Foundation, funding awarded to Marta Cortón, CIBERER (06/07/0036), the University Chair UAM-IIS-FJD of Genomic Medicine, the Ramon Areces Foundation and Regional Government of Madrid (CAM, B2017/BMD3721), funding awarded to Carmen Ayuso. Marta Cortón is sponsored by the Miguel Servet Program (CP12/03256 and CPII17_00006) from ISCIII and Maria Tarilonte received a Conchita Rabago PhD fellowship.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests (Note: Nucleotide sequence data reported are available in the ClinVar database under the accession numbers: SCV000803674 to SCV000803681).
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
*Human PAX6 Mutation Database: http://lsdb.hgu.mrc.ac.uk/home.php?select_db=PAX6.
*HGMD Professional: http://www.biobase-international.com/product/hgmd.
*Human Slicing Finder: http://www.umd.be/HSF.
*SPARN software: http://tools.genes.toronto.edu.
*The Human PAX6 mutation Database: http://lsdb.hgu.mrc.ac.uk/home.php?select_db=PAX6.
*CIBERER Spanish Variant Server: http://csvs.babelomics.org.
- Ansari M, Rainger J, Hanson IM, Williamson KA, Sharkey F, Harewood L, Sandilands A, Clayton-Smith J, Dollfus H, Bitoun P, Meire F, Fantes J, Franco B, Lorenz B, Taylor DS, Stewart F, Willoughby CE, McEntagart M, Khaw PT, Clericuzio C, Van Maldergem L, Williams D, Newbury-Ecob R, Traboulsi EI, Silva ED, Madlom MM, Goudie DR, Fleck BW, Wieczorek D, Kohlhase J, McTrusty AD, Gardiner C, Yale C, Moore AT, Russell-Eggitt I, Islam L, Lees M, Beales PL, Tuft SJ, Solano JB, Splitt M, Hertz JM, Prescott TE, Shears DJ, Nischal KK, Doco-Fenzy M, Prieur F, Temple IK, Lachlan KL, Damante G, Morrison DA, van Heyningen V, FitzPatrick DR (2016) Genetic analysis of ‘PAX6-negative’ individuals with aniridia or gillespie syndrome. PLoS One 11:e0153757. https://doi.org/10.1371/journal.pone.0153757 CrossRefPubMedPubMedCentralGoogle Scholar
- Bayrakli F, Guney I, Bayri Y, Ercan-Sencicek AG, Ceyhan D, Cankaya T, Mason C, Bilguvar K, Bayrakli S, Mane SM, State MW, Gunel M (2009) A novel heterozygous deletion within the 3′ region of the PAX6 gene causing isolated aniridia in a large family group. J Clin Neurosci 16:1610–1614. https://doi.org/10.1016/j.jocn.2009.03.022 CrossRefPubMedGoogle Scholar
- Bhatia S, Bengani H, Fish M, Brown A, Divizia MT, de Marco R, Damante G, Grainger R, van Heyningen V, Kleinjan DA (2013) Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. Am J Hum Genet 93:1126–1134. https://doi.org/10.1016/j.ajhg.2013.10.028 CrossRefPubMedPubMedCentralGoogle Scholar
- Bhatia S, Monahan J, Ravi V, Gautier P, Murdoch E, Brenner S, van Heyningen V, Venkatesh B, Kleinjan DA (2014) A survey of ancient conserved non-coding elements in the PAX6 locus reveals a landscape of interdigitated cis-regulatory archipelagos. Dev Biol 387:214–228. https://doi.org/10.1016/j.ydbio.2014.01.007 CrossRefPubMedGoogle Scholar
- Blanco-Kelly F, Palomares M, Vallespin E, Villaverde C, Martin-Arenas R, Velez-Monsalve C, Lorda-Sanchez I, Nevado J, Trujillo-Tiebas MJ, Lapunzina P, Ayuso C, Corton M (2017) Improving molecular diagnosis of aniridia and WAGR syndrome using customized targeted array-based CGH. PLoS One 12:e0172363. https://doi.org/10.1371/journal.pone.0172363 CrossRefPubMedPubMedCentralGoogle Scholar
- Ceroni F, Aguilera-Garcia D, Chassaing N, Bax DA, Blanco-Kelly F, Ramos P, Tarilonte M, Villaverde C, da Silva LRJ, Ballesta-Martinez MJ, Sanchez-Soler MJ, Holt RJ, Cooper-Charles L, Bruty J, Wallis Y, McMullan D, Hoffman J, Bunyan D, Stewart A, Stewart H, Lachlan K, Study DDD, Fryer A, McKay V, Roume J, Dureau P, Saggar A, Griffiths M, Calvas P, Ayuso C, Corton M, Ragge NK (2018) New GJA8 variants and phenotypes highlight its critical role in a broad spectrum of eye anomalies. Hum Genet. https://doi.org/10.1007/s00439-018-1875-2 CrossRefPubMedGoogle Scholar
- Charbonnier F, Raux G, Wang Q, Drouot N, Cordier F, Limacher JM, Saurin JC, Puisieux A, Olschwang S, Frebourg T (2000) Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 60:2760–2763PubMedGoogle Scholar
- Chassaing N, Causse A, Vigouroux A, Delahaye A, Alessandri JL, Boespflug-Tanguy O, Boute-Benejean O, Dollfus H, Duban-Bedu B, Gilbert-Dussardier B, Giuliano F, Gonzales M, Holder-Espinasse M, Isidor B, Jacquemont ML, Lacombe D, Martin-Coignard D, Mathieu-Dramard M, Odent S, Picone O, Pinson L, Quelin C, Sigaudy S, Toutain A, Thauvin-Robinet C, Kaplan J, Calvas P (2013) Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia. Clin GenetGoogle Scholar
- McBride DJ, Buckle A, van Heyningen V, Kleinjan DA (2011) DNaseI hypersensitivity and ultraconservation reveal novel, interdependent long-range enhancers at the complex Pax6 cis-regulatory region. PLoS One 6:e28616. https://doi.org/10.1371/journal.pone.0028616 CrossRefPubMedPubMedCentralGoogle Scholar
- Ravi V, Bhatia S, Gautier P, Loosli F, Tay BH, Tay A, Murdoch E, Coutinho P, van Heyningen V, Brenner S, Venkatesh B, Kleinjan DA (2013) Sequencing of Pax6 loci from the elephant shark reveals a family of Pax6 genes in vertebrate genomes, forged by ancient duplications and divergences. PLoS Genet 9:e1003177. https://doi.org/10.1371/journal.pgen.1003177 CrossRefPubMedPubMedCentralGoogle Scholar
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30 CrossRefPubMedPubMedCentralGoogle Scholar
- Sanchez-Navarro I, Blanco-Kelly LRJdS, Zurita F, Sanchez-Bolivar O, Villaverde N, Lopez-Molina C, Garcia-Sandoval MI, Tahsin-Swafiri B, Minguez S, Riveiro-Alvarez P, Lorda R, Sanchez-Alcudia I, Perez-Carro R, Valverde R, Liu D, Tian Y, Hakonarson L, Avila-Fernandez H, Corton A, Ayuso M C (2018) Combining targeted panel-based resequencing and copy-number variation analysis for the diagnosis of inherited syndromic retinopathies and associated ciliopathies. Sci Rep 8:5285. https://doi.org/10.1038/s41598-018-23520-1 CrossRefPubMedPubMedCentralGoogle Scholar
- Simioni M, Vieira TP, Sgardioli IC, Freitas EL, Rosenberg C, Maurer-Morelli CV, Lopes-Cendes I, Fett-Conte AC, Gil-da-Silva-Lopes VL (2012) Insertional translocation of 15q25-q26 into 11p13 and duplication at 8p23.1 characterized by high resolution arrays in a boy with congenital malformations and aniridia. Am J Med Genet A 158A:2905–2910. https://doi.org/10.1002/ajmg.a.35603 CrossRefPubMedGoogle Scholar
- Somers J, Wilson LA, Kilday JP, Horvilleur E, Cannell IG, Poyry TA, Cobbold LC, Kondrashov A, Knight JR, Puget S, Grill J, Grundy RG, Bushell M, Willis AE (2015) A common polymorphism in the 5′ UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy. Genes Dev 29:1891–1896. https://doi.org/10.1101/gad.261867.115 CrossRefPubMedPubMedCentralGoogle Scholar
- Vasilyeva TA, Voskresenskaya AA, Kasmann-Kellner B, Khlebnikova OV, Pozdeyeva NA, Bayazutdinova GM, Kutsev SI, Ginter EK, Semina EV, Marakhonov AV, Zinchenko RA (2017) Molecular analysis of patients with aniridia in Russian Federation broadens the spectrum of PAX6 mutations. Clin Genet 92:639–644. https://doi.org/10.1111/cge.13019 CrossRefPubMedGoogle Scholar
- Whiley PJ, de la Hoya M, Thomassen M, Becker A, Brandao R, Pedersen IS, Montagna M, Menendez M, Quiles F, Gutierrez-Enriquez S, De Leeneer K, Tenes A, Montalban G, Tserpelis D, Yoshimatsu T, Tirapo C, Raponi M, Caldes T, Blanco A, Santamarina M, Guidugli L, de Garibay GR, Wong M, Tancredi M, Fachal L, Ding YC, Kruse T, Lattimore V, Kwong A, Chan TL, Colombo M, De Vecchi G, Caligo M, Baralle D, Lazaro C, Couch F, Radice P, Southey MC, Neuhausen S, Houdayer C, Fackenthal J, Hansen TV, Vega A, Diez O, Blok R, Claes K, Wappenschmidt B, Walker L, Spurdle AB, Brown MA, consortium E (2014) Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing. Clin Chem 60:341–352. https://doi.org/10.1373/clinchem.2013.210658 CrossRefPubMedGoogle Scholar